Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers

Shaker A. Mousa; Thangirala Sudha; Evgeny Dyskin; Usawadee Dier; Christine Gallati; Christine Hanko; Sridar V. Chittur; Abdelhadi Rebbaa

doi:10.1016/j.canlet.2009.08.018

Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers

Shaker A. Mousa
, Thangirala Sudha
, Evgeny Dyskin
, Usawadee Dier
, Christine Gallati
, Christine Hanko
, Sridar V. Chittur
, Abdelhadi Rebbaa

Department of Family and Community Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Cancer stem cells are known for their inherent resistance to therapy. Here we investigated whether normal stem cells with acquired resistance to stress can be used to identify novel markers of cancer stem cells. For this, we generated a human embryonic stem cell line resistant to Trichostatin A and analyzed changes in its gene expression. The resistant cells over-expressed various genes associated with tumor aggressiveness, many of which are also expressed in the CD133+ glioma cancer stem cells. These findings suggest that stress-resistant stem cells generated in vitro may be useful for the discovery of novel markers of cancer stem cells.

Original language	English (US)
Pages (from-to)	208-216
Number of pages	9
Journal	Cancer Letters
Volume	289
Issue number	2
DOIs	https://doi.org/10.1016/j.canlet.2009.08.018
State	Published - Mar 28 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1016/j.canlet.2009.08.018

Cite this

@article{615c78631f0047b1afeecf3a663b4644,

title = "Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers",

abstract = "Cancer stem cells are known for their inherent resistance to therapy. Here we investigated whether normal stem cells with acquired resistance to stress can be used to identify novel markers of cancer stem cells. For this, we generated a human embryonic stem cell line resistant to Trichostatin A and analyzed changes in its gene expression. The resistant cells over-expressed various genes associated with tumor aggressiveness, many of which are also expressed in the CD133+ glioma cancer stem cells. These findings suggest that stress-resistant stem cells generated in vitro may be useful for the discovery of novel markers of cancer stem cells.",

author = "Mousa, \{Shaker A.\} and Thangirala Sudha and Evgeny Dyskin and Usawadee Dier and Christine Gallati and Christine Hanko and Chittur, \{Sridar V.\} and Abdelhadi Rebbaa",

note = "Funding Information: This work was supported in part by the Pharmaceutical Research Institute in Albany, NY. ",

year = "2010",

month = mar,

day = "28",

doi = "10.1016/j.canlet.2009.08.018",

language = "English (US)",

volume = "289",

pages = "208--216",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers

AU - Mousa, Shaker A.

AU - Sudha, Thangirala

AU - Dyskin, Evgeny

AU - Dier, Usawadee

AU - Gallati, Christine

AU - Hanko, Christine

AU - Chittur, Sridar V.

AU - Rebbaa, Abdelhadi

N1 - Funding Information: This work was supported in part by the Pharmaceutical Research Institute in Albany, NY.

PY - 2010/3/28

Y1 - 2010/3/28

N2 - Cancer stem cells are known for their inherent resistance to therapy. Here we investigated whether normal stem cells with acquired resistance to stress can be used to identify novel markers of cancer stem cells. For this, we generated a human embryonic stem cell line resistant to Trichostatin A and analyzed changes in its gene expression. The resistant cells over-expressed various genes associated with tumor aggressiveness, many of which are also expressed in the CD133+ glioma cancer stem cells. These findings suggest that stress-resistant stem cells generated in vitro may be useful for the discovery of novel markers of cancer stem cells.

AB - Cancer stem cells are known for their inherent resistance to therapy. Here we investigated whether normal stem cells with acquired resistance to stress can be used to identify novel markers of cancer stem cells. For this, we generated a human embryonic stem cell line resistant to Trichostatin A and analyzed changes in its gene expression. The resistant cells over-expressed various genes associated with tumor aggressiveness, many of which are also expressed in the CD133+ glioma cancer stem cells. These findings suggest that stress-resistant stem cells generated in vitro may be useful for the discovery of novel markers of cancer stem cells.

UR - https://www.scopus.com/pages/publications/76849092704

UR - https://www.scopus.com/pages/publications/76849092704#tab=citedBy

U2 - 10.1016/j.canlet.2009.08.018

DO - 10.1016/j.canlet.2009.08.018

M3 - Article

C2 - 19733430

AN - SCOPUS:76849092704

SN - 0304-3835

VL - 289

SP - 208

EP - 216

JO - Cancer Letters

JF - Cancer Letters

IS - 2

ER -

Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this